13F-HR filed by UBS Group AG
UBS Group AG filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-12, with 9,535 holding rows worth $273,643,423,216.
- Accession
- 0000950123-23-004598
- Filer
- CIK 1610520
- Filed
- 2023-05-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A combination report, 18,413 entries on the cover page, a total value of $273,643,423,216 stated on the cover page (in dollars after the unit check, H1), rows summing to $273,643,423,216 with VALUE read as dollars as filed, 13F file number 028-16612. The quarter's positions are built on this report. The resolved quarter.
Other managers
- reports for this filerUBS ASSET MANAGEMENT (AMERICAS) INC 028-02682
- reports for this filerUBS OCONNOR LLC 028-06327
- included managerUBS Financial Services Inc 028-11496
- included managerUBS AG 028-10396
- included managerUBS Switzerland AG 028-21410
- included managerUBS Europe SE 028-21431
- included managerUBS Bank (Canada) 028-22388
- included managerUBS La Maison de Gestion 028-21440
- included managerUBS Securities LLC 028-21412
- included managerUBS Brasil Administradora de Valores Mobiliarios Ltda 028-21429
- included managerUBS (Monaco) S.A. 028-22657
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BILANDER ACQUISITION CORP | 09001T114 | *W EXP 05/19/202 | 26 | $4 | dollars as filed | |
| CYCLO THERAPEUTICS INC | 23254X110 | *W EXP 12/11/202 | 20 | $4 | dollars as filed | |
| LISATA THERAPEUTICS INC | 128058302 | COM | 1 | $3 | dollars as filed | |
| AMERICAN REBEL HOLDINGS INC | 02919L117 | *W EXP 01/20/202 | 100 | $3 | dollars as filed | |
| PROCAPS GROUP SA | L7756P110 | *W EXP 09/29/202 | 11 | $3 | dollars as filed | |
| FINSERV ACQUISITION CORP II | 31809Y111 | *W EXP 02/17/202 | 60 | $3 | dollars as filed | |
| BRIDGETOWN HOLDINGS LTD | G1355U121 | *W EXP 09/30/202 | 19 | $3 | dollars as filed | |
| TIDEWATER INC NEW | 88642R174 | *W EXP 11/14/202 | 1 | $3 | dollars as filed | |
| CONTRAFECT CORP COM NEW | 212326409 | COM | 1 | $2 | dollars as filed | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 7 | $2 | dollars as filed | |
| BLUE WORLD ACQUISITION CORP | G1263E136 | *W EXP 01/10/202 | 99 | $2 | dollars as filed | |
| MINIM INC | 60365W102 | COM | 20 | $2 | dollars as filed | |
| ALLARITY THERAPEUTICS INC | 016744203 | COM NEW | 1 | $2 | dollars as filed | |
| PEDEVCO CORP C | 70532Y303 | OM PAR | 1 | $1 | dollars as filed | |
| LIZHI INC | 53933L104 | ADS | 1 | $1 | dollars as filed | |
| IMAC HLDGS INC | 44967K112 | *W EXP 02/12/202 | 100 | $1 | dollars as filed | |
| CRESCERA CAP ACQUISITION COR | G26507114 | *W EXP 11/18/202 | 7 | $1 | dollars as filed | |
| ALPINE 4 HOLDINGS INC | 02083E105 | CL A | 1 | $1 | dollars as filed | |
| LIXIANG ED HLDG CO LTD | 53934A115 | SPON ADS | 1 | $1 | dollars as filed | |
| DOMA HOLDINGS INC | 25703A112 | *W EXP 07/28/202 | 76 | $1 | dollars as filed | |
| AGILE THERAPEUTICS INC | 00847L209 | COM NEW | 6 | $1 | dollars as filed | |
| MYSEUMAI INC | 23816M115 | *W EXP 08/17/202 | 1 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
| Northern Star Investment Corp II | 66573W115 | Warrant | 2 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
| AEQUI ACQUISITION CORP | 00775W110 | *W EXP 11/30/202 | 3 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
| ACE GLOBAL BUSINESS ACQU LTD | G0083E110 | *W EXP 02/20/202 | 1 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
| EF HUTTON ACQUISITION CORP I | 28201D117 | *W EXP 11/18/202 | 1 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
| EF HUTTON ACQUISITION CORP I | 28201D125 | RIGHT 11/18/2027 | 1 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
| FAZE HOLDINGS INC | 31423J102 | COMMON STOCK | 1 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
| MOBIV ACQUISITION CORP | 60742N114 | *W EXP 07/31/202 | 1 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
| APEXIGEN INC | 03759B110 | *W EXP 07/29/202 | 6 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
| AXONPRIME INFRSTCTR AQSTN CO | 05467C116 | *W EXP 05/31/202 | 1 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
| BIOMX INC | 09090D111 | *W EXP 10/28/202 | 10 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
| CHAVANT CAPITAL ACQUISITN CO | G2058L111 | *W EXP 99/99/999 | 3 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
| INPIXON | 45790J867 | COMMON | 1 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
| ORION BIOTECH OPPORTUNTES CO | G6780C117 | *W EXP 04/15/202 | 5 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-23-004598 | this filing | 2023-05-12 | acceptance time not in the bulk data set |